HOME >> BIOLOGY >> NEWS
1st International Conference on Cell Therapy for Cardiovascular Disease

The First International Conference on Cell Therapy for Cardiovascular Diseases: A One Day Symposium will consist of a morning and an afternoon session. Presentations will focus on current data in both basic and clinical areas, and will be delivered in a format designed to promote discussion and debate.

During the morning session, local factors that serve to promote or interfere with cell survival will be discussed, followed by a detailed review of cell types under active investigation. This will be followed by a review of cell delivery strategies and methods for evaluating their effects. An open debate over lunch will follow. The afternoon session will consist of a comprehensive review of data from both completed and ongoing clinical trials for both acute and chronic myocardial disease, followed by a question-and-answer session.

The Symposium will bring together the leaders in the field of cardiac myogenesis. It is anticipated that many attendees will have preexisting knowledge of principles, experimental design, and results of completed studies in the field of cell therapy for cardiovascular diseases. A wide cross-section of members of basic and clinical researchers, from academic, industry, and regulatory communities will be in attendance.

Date:
Wednesday, June 16, 2004
8:00 a.m. to 5:00 p.m.

Location:
New York Academy of Medicine
1216 Fifth Avenue
Corner of Fifth Avenue and 103rd Street
New York, NY 10029
Tel: 212-822-7200

Symposium Director:

Warren Sherman, M.D.
Director of Medical Education, Cardiac Catheterization Laboratories
Associate Director, Cardiac Catheterization Laboratories
The Zena and Michael A. Wiener Cardiovascular Institute
The Mount Sinai Hospital, New York

Symposium Co-Directors:

Valentin Fuster, M.D., Ph.D.
Director, The Zena and Michael A. Wiener Cardiovascular Institute and The M
'"/>

Contact: Mount Sinai Press Office
NewsMedia@mssm.edu
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
10-Jun-2004


Page: 1 2

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
3. ConocoPhillips & Conservation International launch Biodiversity Action Plan in Venezuela
4. A room with a view for the International Space Station: Completion of the cupola observation module
5. International symposium on nutritional genomics
6. First International Scientific Conference on Childhood Leukaemia
7. International research conferences at the Villa Vigoni
8. Conservation International & SC Johnson invest in Ecuadors rainforest to offset climate impacts
9. STN International launches Derwent World Patents Index First View
10. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24
11. International critical care doctors release first-ever guidelines for sepsis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/12/2019)... ... November 12, 2019 , ... ... from nonprofit U.S. universities and research institutions for its Instrumentation Grant for ... up to $1.2 million per site for the acquisition of instrumentation, development and ...
(Date:11/7/2019)... (PRWEB) , ... November 07, 2019 , ... R3 Stem ... 50% off through the rest of 2019. The code to use during checkout is ... well. , R3 is the nation’s leader in regenerative therapies with over 12,000 successful ...
(Date:11/5/2019)... ... November 05, 2019 , ... Dr. Lauren Kopp ... dentistry to Seattle, WA, including porcelain veneers , smile makeovers, dental implants, ... University of Washington, Dr. Kopp is passionate about serving her Seattle community with ...
Breaking Biology News(10 mins):
(Date:11/5/2019)... ... November 05, 2019 , ... Focal Healthcare ... Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information ... Bx 2.0 will give urologists across Europe the ability to perform targeted transrectal ...
(Date:11/2/2019)... ... 2019 , ... A clinical trial usually involves many different ... principal investigators, supply chain managers, manufacturers, IRT, CRAs and so on. Lack of ... data, potentially leading to patient risk. , By having a single source of ...
(Date:11/2/2019)... (PRWEB) , ... October 31, 2019 , ... ... released by pharma artificial intelligence pioneer tellic. drug360 brings tellic’s expertise in ... new tool allows researchers to quickly uncover relationships between genes, diseases, variants, phenotypes, ...
(Date:10/30/2019)... ... October 30, 2019 , ... Western University of ... innovation and technology play in educating the next generation of health care providers. ... and presentations by WesternU administrators and representatives of companies working with the University ...
Breaking Biology Technology:
Cached News: